CD7+ T-ALL/LBL

Clinical trials for CD7+ T-ALL/LBL explained in plain language.

Never miss a new study

Get alerted when new CD7+ T-ALL/LBL trials appear

Sign up with your email to follow new studies for CD7+ T-ALL/LBL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cell therapy targets stubborn leukemia after failed transplant

Disease control Recruiting now

This study is testing a new type of cell therapy called CD7-targeted CAR-T cells for patients with T-cell leukemia or lymphoma. The goal is to see if this therapy is safe and effective for patients who still have small amounts of cancer left after receiving a stem cell transplant…

Matched conditions: CD7+ T-ALL/LBL

Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Apr 02, 2026 07:12 UTC

CD7+ T-ALL/LBL

Get alerted when new CD7+ T-ALL/LBL trials appear

New cell therapy targets stubborn leukemia after failed transplant